切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2017, Vol. 10 ›› Issue (05) : 534 -538. doi: 10.3877/cma.j.issn.1674-6902.2017.05.006

所属专题: 文献

论著

芒果苷脂质体的制备及其在Lewis肺癌移植瘤中的抗肿瘤作用及临床意义
李霞1, 吴小程1, 周人杰1,()   
  1. 1. 400037 重庆,第三军医大学新桥医院急诊科
  • 收稿日期:2017-04-25 出版日期:2017-10-20
  • 通信作者: 周人杰
  • 基金资助:
    国家自然科学基金资助项目(30972964)

Preparation of mangiferin liposome and its antitumor effect on transplanted Lewis lung carcinoma and its clinical significance

Xia Li1, Xiaocheng Wu1, Renjie Zhou1,()   

  1. 1. Emergency Department, Xinqiao Hosptial, Third Military Medical University, Chongqing 400037, China
  • Received:2017-04-25 Published:2017-10-20
  • Corresponding author: Renjie Zhou
  • About author:
    Corresponding author: Zhou Renjie, Email:
引用本文:

李霞, 吴小程, 周人杰. 芒果苷脂质体的制备及其在Lewis肺癌移植瘤中的抗肿瘤作用及临床意义[J/OL]. 中华肺部疾病杂志(电子版), 2017, 10(05): 534-538.

Xia Li, Xiaocheng Wu, Renjie Zhou. Preparation of mangiferin liposome and its antitumor effect on transplanted Lewis lung carcinoma and its clinical significance[J/OL]. Chinese Journal of Lung Diseases(Electronic Edition), 2017, 10(05): 534-538.

目的

探讨水溶性芒果苷脂质体对Lewis肺癌的治疗作用。

方法

采用薄膜法制备芒果苷脂质体,并对其形态粒径进行表征。MTT法测定其对Lewis肺癌细胞的抗增殖作用;流式细胞术测定其对Lewis肺癌细胞凋亡作用的影响;建立小鼠Lewis肺癌移植瘤模型,检测芒果苷脂质体体内抗肿瘤效果并采用。TUNEL法原位测定其对凋亡的影响。

结果

芒果苷脂质体为均匀的球状或近球状,平均粒径为(207.2±2)nm。MTT实验结果显示,芒果苷脂质体对Lewis肺癌细胞抑制作用显著高于游离芒果苷(P<0.05),与Lewis肺癌细胞作用12 h后芒果苷IC50为(45.2±5.1)μg/ml,芒果苷脂质体IC50为(32.7±4.6)μg/ml。作用24 h后,芒果苷IC50为(22.0±3.9)μg/ml,芒果苷脂质体IC50为14.8±2.7 μg/ml。而芒果苷脂质体在体内动物实验中同样表现出抗肿瘤活力,结果显示通过小鼠尾静脉给药后,可显著抑制Lewis移植瘤在小鼠体内的生长并且与对照组相比可延长生存期超过3 d。同时,流式细胞术分析Lewis细胞凋亡实验及TUNEL法原位检测肿瘤组织细胞凋亡结果均显示芒果苷脂质体可以诱导Lewis肺癌细胞凋亡。

结论

芒果苷脂质体可用于静脉注射改善芒果苷水溶性问题,同时提高其抗肿瘤效应。

Objective

To prepare water soluble mangiferin liposome and observe its effect on inhibiting the growth of transplanting Lewis lung carcinoma.

Method

Mangiferin liposome was prepared by film dispersion methodo. The shape, particles size of the liposome was characterized. Anti-proliferation and apoptosis effects induced by mangiferin liposome on the Lewis lung carcinoma cells were determined by MTT method and flow cytometric analysis in vitro. The model of mice carried Lewis lung carcinoma was established. The effect of mangiferin liposome on anti-tumor and apoptosis in vivo was investigated.

Result

The result of electromicrography showed that the liposomes consisted of small spherical or similar to spherical. The average diameter of mangiferin liposome was 207.2±2 nm. Meanwhile, the results of MTT indicated that Mangiferin liposome could more effective inhibit the proliferation of Lewis lung carcinoma than free Mangiferin (P<0.05). The IC50 of Mangiferin liposome is 32.7±4.6 μg/ml on 12 h after Mangiferin treatment and the IC50 of free Mangiferin is 45.2±5.1 μg/ml on the same time point. 24 hours later, the IC50 of Mangiferin liposome is14.8±2.7 μg/ml. In contrast, the IC50 of free Mangiferin is 22.0±3.9 μg/ml. The results in vivo also exhibited the anti-tumor effect of Mangiferin liposmes. Mangiferin liposmes could suppressed tumor growth efficiently and prolong the survival time more than 3days as control group. Furthermore, both flow cytometry of Lewis cell and TUNEL assay indiacated that mangiferin liposomes could induce apoptosis of Lewis lung carcinoma cells both in vitro and in vivo in our studies.

Conclusion

Liposome delivery system could effectively improve water solubility of mangiferin, and promote the anti-tumor effect.

图1 芒果苷脂质体粒径测定及形态学研究;注:A:芒果苷脂质体透射电镜照片(×30 000);B:芒果苷脂质体粒径测定结果
图2 芒果苷脂质体对Lewis肺癌细胞生长的抑制作用;注:A:芒果苷结构式;B:芒果苷脂质体及芒果苷在12或24 h时IC50;C:12 h时芒果苷及芒果苷脂质体对Lewis肺癌细胞抑制率;D:24 h时芒果苷及芒果苷脂质体对Lewis肺癌细胞抑制率(*P<0.05)
图3 芒果苷脂质体对Lewis肺癌细胞周期的影响;注:A:不同细胞周期细胞百分比;B:流式细胞仪检测不同组Lewis肺癌细胞细胞周期情况
图4 芒果苷脂质体对Lewis肺癌体内抑制情况;注:A:生存期;B:治疗后肿瘤体积变化
图5 芒果苷脂质体原位诱导凋亡情况;注:A:模型组;B:芒果苷脂质体组
1
钱桂生. 肺癌不同病理类型发病率的变化情况及其原因[J/CD]. 中华肺部疾病杂志(电子版), 2011, 4(1): 1-6.
2
支修益,石远凯,于金明. 中国原发性肺癌诊疗规范(2015年版)[J]. 中华肿瘤杂志,2015, 37(1): 67-92.
3
姚晓军,刘伦旭. 肺癌的流行病学及治疗现状[J]. 现代肿瘤医学,2014, 22(8): 1982-1986.
4
Xu X, Chen Y, Song J, et al. Mangiferin suppresses endoplasmic reticulum stress in perivascular adipose tissue and prevents insulin resistance in the endothelium[J]. Eur J Nutr, 2017, doi: 10.1007/s00394-017-1441-z.
5
Dar A, Faizi S, Naqvi S, et al. Analgesic and antioxidant activity of mangiferin and its derivatives: The structure activity relationship[J]. Biol Pharm Bull, 2005, 28(4): 596-600.
6
Guha S, Ghosal S, Chattopadhyay U. Antitumor, immunomodulatory and anti-HIV effect of mangiferin, a naturally occurring glucosylxanthone[J].Chemotherapy, 1996, 42(6): 443-451.
7
Duang XY, Wang Q, Zhou XD, et al. Mangiferin: A possible strategy for periodontal disease to therapy[J]. Med Hypotheses, 2011, 76(4): 486-488.
8
García-Rivera D, Delgado R, Bougarne N, et al. Gallic acid indanone and mangiferin xanthone are strong determinants of immunosuppressive anti-tumour effects of Mangifera indica L[J] . Cancer Lett, 2011, 305(1): 21-31.
9
Noratto GD, Bertoldi MC, Krenek K, et al. Talcott SU: Anticarcinogenic effects of polyphenolics from mango (Mangifera indica) varieties[J]. J Agric Food Chem, 2010, 58(7): 4104-4112.
10
Chieli E, Romiti N, Rodeiro I, et al. In vitro effects of Mangifera indica and polyphenols derived on ABCB1/P-glycoprotein activity[J]. Food Chem Toxicol, 2009, 47(11): 2703-2710.
11
Cheng P, Peng ZG, Yang J, et al. The effect of mangiferin on telomerase activity and apoptosis in leukemic K562 cells[J]. Zhong Yao Cai, 2007, 30(3): 306-309.
12
吕建珍,于洋,邓源,等. 芒果苷对肺癌A549细胞增殖与凋亡的影响[J]. 四川大学学报(自然科学版), 2013, 50(3): 611-614.
13
Peramaiyan R, Ganapathy E, Dhanapal S. Protective role of mangiferin against Benzo(a)pyrene induced lung carcinogenesis in experimental animals[J]. Biol Pharm Bull, 2008, 31(6): 1053-1058.
14
JoséRobertor DS, JoseéIvanx DC, Mariateresas T, et al. Chitosancoated pectin beads: Characterization and in vitro release of mangiferin[J]. Food Hydrocolloids, 2009, 23(8): 2278-2286.
15
Dicheva BM, Ten hagen TL, Li L, et al. Cationic thermosensitive liposomes: a novel dual targeted heattriggered drug delivery approach for endothelial and tumor cells[J]. Nano Lett, 2013, 13(6): 2324-2331.
16
Lin J, Gill A, Zahm SH, et al. Metformin use and survival after non-small cell lung cancer: A cohort study in the U.S. military health system[J]. Int J Cancer, 2017, 141(2): 254-263.
17
方楚玲,郭琳琅. miRNA对肺癌化疗耐药调控研究进展[J]. 中华肿瘤防治杂志,2014, 21(1): 72-76.
18
张永军,张爱琴,包文龙,等. 榄香烯抑制p21基因表达逆转肺癌化疗耐药的实验研究[J]. 中华中医药学刊,2015, 51(12): 59-61.
19
Zhu L, Wang Z, Zhai X, Sui Z, et al. Simultaneous quantitative determination of 13 active components in the traditional Chinese medicinal preparation Suanzaoren oral liquid by HPLC coupled with diode array detection and evaporative light scattering detection[J]. J Sep Sci, 2017, 40(11): 2320-2325.
20
Gold-Smith F, Fernandez A, Bishop K. Mangiferin and Cancer: Mechanisms of Action[J]. Nutrients, 2016, 8(7): E396.
21
Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
22
Witschi H, Uyeminami D, Moran D, et al. Chemoprevention of tobacco-smoke lung carcinogenesis in mice after cessation of smoke exposure[J]. Carcinogenesis, 2000, 21(5): 977-982.
23
Niedzwiecki A, Roomi MW, Kalinovsky T, et al. Anticancer efficacy of polyphenols and their combinations[J]. Nutrients, 2016, 8(9): E552.
[1] 张刚, 秦勇, 黄超, 薛震, 吕松岑. 基于骨关节炎软骨细胞表型转化的新兴治疗靶点[J/OL]. 中华关节外科杂志(电子版), 2024, 18(03): 352-362.
[2] 钟雅雯, 王煜, 王海臻, 黄莉萍. 肌苷通过抑制线粒体通透性转换孔开放缓解缺氧/复氧诱导的人绒毛膜滋养层细胞凋亡[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 525-533.
[3] 孙鸿坤, 艾虹, 陈正. 内质网应激介导的牙周炎骨改建失衡的研究进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(04): 211-218.
[4] 黄福, 王黔, 金相任, 唐云川. VEGFR2、miR-27a-5p在胃癌组织中的表达与临床病理参数及预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 558-561.
[5] 祝炜安, 林华慧, 吴建杰, 黄炯煅, 吴婷婷, 赖文杰. RDM1通过CDK4促进前列腺癌细胞进展的研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 618-625.
[6] 郑俊, 吴杰英, 谭海波, 郑安全, 李腾成. EGFR-MEK-TZ三联合分子的构建及其对去势抵抗性前列腺癌细胞增殖与凋亡的影响[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 503-508.
[7] 赵蒙蒙, 黄洁, 余荣环, 王葆青. 过表达小GTP酶Rab32抑制非小细胞肺癌细胞侵袭性生长[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 512-518.
[8] 黄程鑫, 陈莉, 刘伊楚, 王水良, 赖晓凤. OPA1 在乳腺癌组织的表达特征及在ER阳性乳腺癌细胞中的生物学功能研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 275-284.
[9] 季加翠, 孙春斌, 罗恩丽. 姜黄素通过调节NF-κB/NLRP3通路减轻LPS诱导小胶质细胞神经炎症损伤[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(04): 193-203.
[10] 曾聿理, 雷发容, 肖慧, 邱德亮, 谢静, 吴寻. 氯普鲁卡因通过调控circRNA-ZKSCAN1表达抑制肝癌Huh-7细胞体外生长和转移的研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(04): 220-228.
[11] 李晶, 潘侠, 周芳, 汪晶, 洪佳. 普鲁卡因通过上调lncRNA DGCR5抑制胃癌细胞增殖、迁移和侵袭[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(03): 151-158.
[12] 李博, 马秀岩, 孙杰. lncRNA TINCR对滋养层HTR-8/SVneo细胞生物学行为的影响及其机制[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(03): 167-172.
[13] 杨兴业, 彭旭云, 曾倩, 梁伟铖, 肖翠翠, 郑俊, 姚嘉. LMO7通过靶向铁死亡促进肝细胞癌生长[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 370-376.
[14] 杜霞, 马梦青, 曹长春. 造影剂诱导的急性肾损伤的发病机制及干预靶点研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 279-282.
[15] 李景德, 张保艳, 卢培刚, 李博. 法舒地尔对大鼠急性脊髓损伤后神经细胞凋亡和BCL-2蛋白表达水平的影响[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(02): 65-70.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?